Metraipolis › archive › dc_4f06cba45672

Sustained improvement in renal function with palopegteriparatide in adults with chronic hypoparathyroidism: 2-year results from the phase 3 PaTHway-trial — Europe PMC PMID:42166177

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42166177
DOI
10.1093/jbmr/zjag085
License (as archived)
solo-consultazione
Archived
2026-10-16T01:29:34.797Z
SHA-256 of the archived text
bcc711c2472e204844a1070cfa70471918c875495e8d862c6671443e57a3ccd6
Stable URL of this page
https://metraipolis.com/documento/dc_4f06cba45672

How to cite

Sustained improvement in renal function with palopegteriparatide in adults with chronic hypoparathyroidism: 2-year results from the phase 3 PaTHway-trial — Europe PMC PMID:42166177 — Europe PMC (en), https://europepmc.org/article/MED/42166177 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4f06cba45672 (Metraipolis archive dc_4f06cba45672, sha256 bcc711c2472e204844a1070cfa70471918c875495e8d862c6671443e57a3ccd6)
BibTeX
@misc{dc4f06cba45672,
  title = {Sustained improvement in renal function with palopegteriparatide in adults with chronic hypoparathyroidism: 2-year results from the phase 3 PaTHway-trial — Europe PMC PMID:42166177},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42166177},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4f06cba45672; sha256 bcc711c2472e204844a1070cfa70471918c875495e8d862c6671443e57a3ccd6},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42166177. Agents can read the archived copy with the MCP tool read_document.